BRIEF-Teva Announces FDA Approval Of Trisenox To Treat Acute Promyelocytic Leukemia
January 15, 2018 at 08:24 AM EST
* TEVA ANNOUNCES U.S. FDA APPROVAL OF TRISENOX® (ARSENIC TRIOXIDE) INJECTION FOR FIRST LINE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA